Ahmed Nader, PhD, FCP

Senior Director and Research Fellow, CPMS-VxID TA Head (Interim)
Clinical Pharmacology, Modelling and Simulation, GSK, Collegeville, Pennsylvania, USA

Poster(s):

• 049: Assessment of the Effect of HBV Viral Genotype on Bepirovirsen Efficacy Using a Population Pharmacokinetic/Pharmacodynamic Modeling Approach
  Sunday, September 8, 2024

  5:00 PM - 7:00 PM ET